Richard Vosser
Stock Analyst at J.P. Morgan
(3.37)
# 2,360
Out of 4,501 analysts
1210
Total ratings
50.1%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | $13,104.00 | +22.10% | 32 | Jul 9, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 | $50.08 | -0.16% | 144 | Jul 8, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €95.00 | $76.34 | +24.44% | 163 | Jul 6, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | n/a | $165.00 | - | 16 | Jun 29, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 250.00 | $320.55 | -22.01% | 155 | Jun 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €295.00 | $243.20 | +21.30% | 74 | Jun 22, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €260.00 | $185.30 | +40.31% | 28 | Jun 22, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €150.00 | $140.75 | +6.57% | 145 | Jun 1, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | $125.04 | +7.97% | 118 | May 5, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 325.00 | $338.60 | -4.02% | 191 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €950.00 | $791.40 | +20.04% | 3 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1,977.50 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $925 → $1,100 | $909.49 | +20.95% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €230.00 → €300.00 | $250.17 | +19.92% | 19 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 3.50 → CHF 3.00 | $3.18 | -5.66% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $48.88 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $154.62 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $4.02 | -0.59% | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 → €260.00 | $197.60 | +31.58% | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 645.00 → CHF 650.00 | $588.80 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.00 → €3.50 | $1.27 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $54 → $39 | $14.44 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €43.68 | $51.35 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,000p | $1,609.00 | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $176 | $42.78 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $52.02 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $142.74 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $205 → $200 | $30.59 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | $26.66 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 1,150 | $1,888.98 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.78 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $43.90 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $7.29 | n/a | 1 | Jan 4, 2017 |
AstraZeneca PLC
Jul 9, 2026
Maintained: Buy
Price Target: 16,000p
Current: $13,104.00
Upside: +22.10%
Bayer Aktiengesellschaft
Jul 8, 2026
Maintained: Buy
Price Target: €50.00
Current: $50.08
Upside: -0.16%
Sanofi
Jul 6, 2026
Maintained: Hold
Price Target: €95.00
Current: $76.34
Upside: +24.44%
Ipsen S.A.
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $165.00
Upside: -
Novo Nordisk A/S
Jun 29, 2026
Maintained: Hold
Price Target: kr 250.00
Current: $320.55
Upside: -22.01%
Sartorius Aktiengesellschaft
Jun 22, 2026
Maintained: Buy
Price Target: €295.00
Current: $243.20
Upside: +21.30%
Sartorius Stedim Biotech S.A.
Jun 22, 2026
Maintained: Buy
Price Target: €260.00
Current: $185.30
Upside: +40.31%
Merck KGaA
Jun 1, 2026
Maintained: Buy
Price Target: €150.00
Current: $140.75
Upside: +6.57%
Novartis AG
May 5, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: $125.04
Upside: +7.97%
Roche Holding AG
May 1, 2026
Maintained: Hold
Price Target: CHF 325.00
Current: $338.60
Upside: -4.02%
Mar 5, 2026
Maintained: Buy
Price Target: €950.00
Current: $791.40
Upside: +20.04%
Dec 23, 2025
Maintained: Sell
Price Target: n/a
Current: $1,977.50
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $925 → $1,100
Current: $909.49
Upside: +20.95%
Dec 8, 2025
Maintained: Buy
Price Target: €230.00 → €300.00
Current: $250.17
Upside: +19.92%
Dec 8, 2025
Maintained: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: $3.18
Upside: -5.66%
Nov 24, 2025
Maintained: Buy
Price Target: n/a
Current: $48.88
Upside: -
Nov 20, 2025
Maintained: Hold
Price Target: n/a
Current: $154.62
Upside: -
Sep 3, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $4.02
Upside: -0.59%
Jul 22, 2025
Maintained: Buy
Price Target: €250.00 → €260.00
Current: $197.60
Upside: +31.58%
Dec 3, 2024
Maintained: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: $588.80
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: €3.00 → €3.50
Current: $1.27
Upside: n/a
Dec 5, 2023
Maintained: Hold
Price Target: $54 → $39
Current: $14.44
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €43.68
Current: $51.35
Upside: n/a
Sep 27, 2021
Maintained: Buy
Price Target: 3,000p
Current: $1,609.00
Upside: n/a
Mar 18, 2021
Maintained: Buy
Price Target: $176
Current: $42.78
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: n/a
Current: $52.02
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $142
Current: $142.74
Upside: n/a
Mar 2, 2020
Maintained: Hold
Price Target: $205 → $200
Current: $30.59
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: $26.66
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: kr 1,150
Current: $1,888.98
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $29.78
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $43.90
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $7.29
Upside: n/a